NCT00624481View on ClinicalTrials.gov

Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMD

PHASE2WithdrawnINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
OsteopeniaOsteoporosis
Interventions
DRUG

Teriparatide

20ug subcutaneous injection daily for 24 weeks

DRUG

Teriparatide Nasal Spray

teriparatide intranasally daily for 24 weeks

DRUG

Teriparatide Nasal Spray

teriparatide intranasally daily for 24 weeks

DRUG

Teriparatide Nasal Spray

teriparatide intranasally daily for 24 weeks

DRUG

Teriparatide Nasal Spray

teriparatide intranasally daily for 24 weeks

Sponsors
All Listed Sponsors
lead

Nastech Pharmaceutical Company, Inc.

INDUSTRY